Hormone replacement therapy (HRT) does not appear to increase the risk of death from either heart disease or cancer. That’s what researchers concluded by analyzing data from the long-running Women’s Health Initiative study.
Researchers have used modified stem cells to deliver a cancer drug selectively to metastatic breast cancer tumors in mice. The stem cells specifically targeted metastatic tumors by homing in on the stiff environment that typically surrounds them.
Using this method, the team screened the blood samples for mutations within 58 known cancer-related genes. They detected no tumor-derived mutations in the blood samples from the healthy people. However, in the samples from patients with colorectal, breast, lung, or ovarian cancer, the technique identified tumor-related DNA mutations in 48 of 62 patients (77%) with advanced cancer (stages III and IV) and in 86 of 138 patients (62%) with stage I or stage II cancer.
In the study, mice with breast cancer who were given chemotherapy, had double the number of cancer cells in the lungs and bloodstream, compared to mice that did not receive the treatment. Moreover, scientists found that chemotherapy made blood vessels more permeable to cancer cells. Immune cells that transport cancer cells also increased. Chemotherapy has been found to promote cancer spread in humans as well. In twenty patients who received chemotherapy drugs, it was discovered that tumor microenvironments became increasingly favorable for cancer metastasis.
Mushrooms are being studied to find out how they affect the immune system and if they stop or slow the growth of tumors or kill tumor cells. It is thought that certain chemical compounds, such as polysaccharides in turkey tail mushrooms, strengthen the immune system to fight cancer.
Food choice plays an important role in whether or not a woman develops breast cancer during her lifetime. In the study, lab mice were given one of three diets: either high in fructose or sucrose similar to the typical Western diet, starch-rich meals or a control group with a low-sugar and starch diet. The results were sobering. After six months, 30 percent of mice fed starches developed breast cancer, while the sugar-rich diet mice had a 50-58 percent breast cancer rate, compared to the control group. “We determined that it was specifically fructose, in table sugar and high-fructose corn syrup, ubiquitous within our food system, which was responsible for facilitating lung metastasis and 12-HETE production in breast tumors,” said co-author Lorenzo Cohen, Ph.D., professor of Palliative, Rehabilitation, and Integrative Medicine at MD Anderson.
A particular concern of breast cancer recurrence is raised for patients with estrogen receptor (ER)-positive tumors because this type of breast cancer is fueled by the hormone estrogen, of which levels increase during pregnancy. This could cause an unwanted growth of cancer cells that potentially remained in the body after treatment. However, this study shows no differences in survival among ER-positive cancer participants that became pregnant, compared to those who did not. When it came to ER-negative cancer participants, a significant difference was found in the survival of participants. Pregnancy lowered the chances of dying by 42 percent in this group of survivors.
In the study, published in Breast Cancer Research and Treatment, higher intake of cruciferous vegetables and soy foods were associated with fewer reports of menopausal symptoms. Higher soy intake was also associated with less reported fatigue. The breast cancer survivors studied included 173 non-Hispanic white and 192 Chinese Americans including US-born Chinese and Chinese immigrants.
Janssen and Leading Advocacy Organizations Introduce Cancer.com, a Customizable Online Destination for People Impacted by Cancer
The Janssen Pharmaceutical Companies of Johnson & Johnson are proud to announce the launch of Cancer.com, an online destination providing those impacted by cancer with useful information and tools at the right time. It features content tailored to each visitor by cancer type, topics of interest, and where they are in their care journey. Cancer.com also offers support tools to help visitors build skills to navigate life with cancer. It was created by Janssen Oncology in collaboration with leading patient advocacy organizations: the American Cancer Society, CancerCare, and Cancer Support Community.
Peter A. Kaufman, MD of the Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, said: “This new indication for Faslodex offers another treatment option for women living with HR+, HER2- advanced or metastatic breast cancer with disease progression after endocrine therapy. The study supporting this indication demonstrated that Faslodex used in combination with abemaciclib significantly improves progression-free survival compared to Faslodex and placebo.”
I’m guessing that you wouldn’t intentionally swallow Monsanto’s Roundup, particularly after it has been classified as a probable carcinogen by the World Health Organization and has recently been added to California’s list of cancer-causing substances. But you may be getting a lot more of the main ingredient, known as glyphosate, than you want in your daily diet. That’s because a recent study by the Canadian Food Inspection Agency (CFIA) found the highest amount of glyphosate in foods most people might never suspect as problematic. Worse than that, the study found that nearly one-third of all foods tested now contain glyphosate.
A study led by the nonprofit Orb Media concludes that tap water in dozens of nations contains extremely high levels of plastic microfibers. The contamination rate was highest in the United States.
GE Healthcare won FDA clearance for the first mammography system, the Senographe Pristina Dueta, that lets women undergoing an exam to control how much the device compresses the breasts. As the woman is prepared for the exam, she is handed a small remote control that has a plus and minus buttons on it. The breast is then positioned by the technologist between the compression plates and from then on the patient has control in terms of how much compression she’s willing to take.
Using a modern DNA sequencing technique, Johns Hopkins researchers have come one step closer to diagnosing early-stage cancer patients with a simple blood draw. The method reads free circulating DNA in a patient’s blood and detects common cancer mutations. While further refinement is needed, it was able to identify three out of every five people with early-stage colorectal, ovarian, breast or lung cancer.
Here is a link to the California Division of Environmental and Occupational Disease Control of the California Department of Public Health. The overview states:
“Although the science is still evolving , some laboratory experiments and human health studies have suggested the possibility that long-term, high use of cell phones may be linked to certain types of cancer and other health effects
Vaccines proved to be a game changer in modern medicine. The fight isn’t over yet, however; cancer, infectious diseases, and autoimmune conditions still plague humanity to this day. Might 2018 see the tipping point in this war?
We already know that there are a lot of elements in our environment that interfere with our hormones. Even something as simple as light pollution can throw them out of whack. Heck, we even electively choose to alter our natural hormonal clocks with medications. With all these assailants present in our environment, you may be interested in eliminating hormonal impactors wherever possible. A great place to start? Your food. Steer clear of these five foods that are known to impact hormonal balance
Two new studies show that women treated for early stage breast cancer may suffer from the numbness, tingling or pain of peripheral neuropathy in their feet for years afterwards. Relatively few studies of chemotherapy effectiveness actually follow up on such side effects, which can have a big impact on quality of life. To determine how common peripheral neuropathy might be, the investigators examined data from more than 1,500 breast cancer patients in the National Surgical Adjuvant Breast and Bowel Project Protocol B-30. After two years of treatment, about 42 percent of the patients reported neuropathy, with 10 percent in severe pain. Analysis showed that lower-dose docetaxel combinations to treat this cancer were less likely to trigger peripheral neuropathy. However, older or heavier breast cancer survivors appear to be more vulnerable.
Once upon a time, biotech companies selling genetically engineered crops had a fig leaf of cover to claim their products were absolutely non-toxic. Today, we have nothing but the naked truth. The new varieties come with instructions to shower them in toxic herbicides. How on earth can that be good in any way?